)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Orchid Pharma
Orchid Pharma (ORCHPHARMA) investor relations material
Orchid Pharma Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary12 Feb, 2026
Executive summary
Q3 FY26 sales were INR 207 crore, down 5% year-over-year; nine-month sales at INR 574 crore, down 16% year-over-year.
EBITDA margin for Q3 was 6% versus 17% last year; nine-month EBITDA at INR 58 crore, margin at 10% versus 17% last year.
Profit before tax (PBT) and profit after tax (PAT) for Q3 FY26 were both INR 7 crore, compared to a loss of INR 6 crore in Q3 FY25.
Board approved unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, with limited review by statutory auditors.
Global antibiotics market remains under stress, with pricing pressure and volume erosion in oral segment.
Financial highlights
Q3 sales: INR 207 crore (down 5% YoY); nine-month sales: INR 574 crore (down 16% YoY).
Q3 EBITDA: INR 13 crore (down 65% YoY); nine-month EBITDA: INR 58 crore (down 50% YoY).
Gross margin for Q3 at 31%, lower due to reduced regulated market sales and inventory devaluation.
Standalone total income for Q3 FY26 was INR 217.34 crore, up from INR 207.27 crore in Q2 FY26 and INR 193.52 crore in Q3 FY25.
Domestic business is 20% of revenue, exports 80%; regulated markets now 25% of exports.
Outlook and guidance
FY26 is a transition year; medium-term outlook positive with new product launches and cost discipline.
Sequential sales recovery observed from Q3 FY25 to Q3 FY26, but overall year-over-year decline persists.
Green shoots of recovery seen in January, but sustainability remains uncertain.
Gross margins expected to improve as non-regulated market pricing recovers; regulated market margins remain 40%-65%.
Guidance for future segments and merged business to be provided next quarter.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Orchid Pharma earnings date
Q4 25/2622 May, 2026
Orchid Pharma
Next Orchid Pharma earnings date
Q4 25/2622 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Orchid Pharma Limited is a pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished dosage formulations. The company focuses on therapeutic areas such as anti-infectives, including beta-lactam antibiotics, and also operates in segments like cardiovascular and central nervous system treatments. Its operations include research and development, chemical synthesis, and formulation development for both domestic and international markets. The company is headquartered in Chennai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage